Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 31% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 152.33 | 573 / 578 | 90% | 5.33 | 1034 / 1155 |
stomach | 87% | 92.85 | 314 / 359 | 81% | 4.43 | 232 / 286 |
thymus | 89% | 81.68 | 583 / 653 | 60% | 17.41 | 365 / 605 |
intestine | 66% | 165.61 | 637 / 966 | 77% | 2.93 | 407 / 527 |
prostate | 84% | 52.13 | 205 / 245 | 59% | 1.62 | 295 / 502 |
breast | 65% | 32.82 | 299 / 459 | 74% | 4.28 | 825 / 1118 |
uterus | 65% | 22.46 | 110 / 170 | 67% | 3.15 | 306 / 459 |
esophagus | 52% | 30.78 | 757 / 1445 | 75% | 3.20 | 138 / 183 |
bladder | 62% | 71.43 | 13 / 21 | 62% | 2.36 | 310 / 504 |
kidney | 53% | 36.92 | 47 / 89 | 71% | 4.55 | 636 / 901 |
pancreas | 33% | 10.04 | 107 / 328 | 72% | 3.24 | 128 / 178 |
spleen | 100% | 687.58 | 241 / 241 | 0% | 0 | 0 / 0 |
skin | 34% | 11.73 | 621 / 1809 | 64% | 5.41 | 302 / 472 |
lymph node | 0% | 0 | 0 / 0 | 97% | 22.61 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 91% | 9.08 | 41 / 45 |
liver | 57% | 19.87 | 128 / 226 | 34% | 2.64 | 139 / 406 |
adipose | 86% | 46.79 | 1036 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 518.85 | 784 / 929 | 0% | 0 | 0 / 0 |
ovary | 21% | 7.46 | 37 / 180 | 54% | 1.56 | 233 / 430 |
adrenal gland | 44% | 14.78 | 114 / 258 | 12% | 0.32 | 28 / 230 |
blood vessel | 41% | 23.22 | 543 / 1335 | 0% | 0 | 0 / 0 |
heart | 19% | 5.97 | 160 / 861 | 0% | 0 | 0 / 0 |
brain | 7% | 2.28 | 198 / 2642 | 8% | 0.18 | 59 / 705 |
eye | 0% | 0 | 0 / 0 | 14% | 0.62 | 11 / 80 |
muscle | 2% | 0.65 | 17 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070228 | Biological process | regulation of lymphocyte apoptotic process |
GO_0046629 | Biological process | gamma-delta T cell activation |
GO_0007163 | Biological process | establishment or maintenance of cell polarity |
GO_0046631 | Biological process | alpha-beta T cell activation |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0002250 | Biological process | adaptive immune response |
GO_0015031 | Biological process | protein transport |
GO_0045059 | Biological process | positive thymic T cell selection |
GO_0042110 | Biological process | T cell activation |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0042105 | Cellular component | alpha-beta T cell receptor complex |
GO_0005829 | Cellular component | cytosol |
GO_0042106 | Cellular component | gamma-delta T cell receptor complex |
GO_0042608 | Molecular function | T cell receptor binding |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CD3G |
Protein name | TCR Ti gamma-chain V9-J2 region T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g) TCR Ti gamma-chain V8-J2 region CD3 gamma subunit of T-cell receptor complex |
Synonyms | T3G hCG_1646880 |
Description | FUNCTION: Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways . In addition to this role of signal transduction in T-cell activation, CD3G plays an essential role in the dynamic regulation of TCR expression at the cell surface . Indeed, constitutive TCR cycling is dependent on the di-leucine-based (diL) receptor-sorting motif present in CD3G. . |
Accessions | ENST00000392883.6 A8MUH3 A2N8H5 P09693 ENST00000528540.5 A0A3B3IUD8 ENST00000292144.8 B0YIY5 ENST00000532917.3 A2N8H4 J3KNA5 |